BioNeutra Global Statistics

Total Valuation

TSXV:BGA has a market cap or net worth of CAD 1.39 million. The enterprise value is 8.14 million.

Market Cap	1.39M
Enterprise Value	8.14M

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

TSXV:BGA has 46.45 million shares outstanding.

Current Share Class	46.45M
Shares Outstanding	46.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.68%
Owned by Institutions (%)	n/a
Float	29.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.13
PB Ratio	-0.17
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.34
EV / Sales	0.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.21

Financial Position

The company has a current ratio of 0.35

Current Ratio	0.35
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-13.16
Interest Coverage	-1.03

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-3.43%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	49.75%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.74
Inventory Turnover	1.99

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.50% in the last 52 weeks. The beta is 0.85, so TSXV:BGA's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-62.50%
50-Day Moving Average	0.03
200-Day Moving Average	0.03
Relative Strength Index (RSI)	26.09
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:BGA had revenue of CAD 10.86 million and -610,205 in losses. Loss per share was -0.02.

Revenue	10.86M
Gross Profit	4.65M
Operating Income	-806,788
Pretax Income	-610,205
Net Income	-610,205
EBITDA	-349,515
EBIT	-806,788
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 796,540 in cash and 7.54 million in debt, giving a net cash position of -6.75 million or -0.15 per share.

Cash & Cash Equivalents	796,540
Total Debt	7.54M
Net Cash	-6.75M
Net Cash Per Share	-0.15
Equity (Book Value)	-8.23M
Book Value Per Share	-0.18
Working Capital	-9.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -500,503 and capital expenditures -72,468, giving a free cash flow of -572,971.

Operating Cash Flow	-500,503
Capital Expenditures	-72,468
Free Cash Flow	-572,971
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 42.84%, with operating and profit margins of -7.43% and -5.62%.

Gross Margin	42.84%
Operating Margin	-7.43%
Pretax Margin	-5.62%
Profit Margin	-5.62%
EBITDA Margin	-3.22%
EBIT Margin	-7.43%
FCF Margin	n/a

Dividends & Yields

TSXV:BGA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-43.79%
FCF Yield	-41.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSXV:BGA has an Altman Z-Score of -2.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.05
Piotroski F-Score	3